Tech Company Financing Transactions
Juno Therapeutics Funding Round
Juno Therapeutics, based in Seattle, secured $31 million in investment from Bezos Expeditions, private investors and Venrock.
Transaction Overview
Company Name
Announced On
4/24/2014
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series A
Investors
Venrock (Anthony Evnin)
Proceeds Purpose
Juno's initial funding of $120 million came predominantly from leading technology venture capital firm ARCH Venture Partners and the Alaska Permanent Fund, through a partnership managed by Crestline Investors. The completion of the A round includes expansions from founding investors as well as investments from Bezos Expeditions, the personal investment company of Jeff Bezos, and Venrock, amongst others.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
307 Westlake Avenue North 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Overview
Juno is a clinical-stage company that brings together three of the world's leading cancer centers -- Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute -- in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Bishop
Chief Financial Officer
Steve Harr
Chief Medical Officer
Mark Gilbert
Chief Scientific Officer
Ken Mohler
VP - General Counsel
Barney Cassidy
VP - Human Resources
Robin Andrulevich
VP - Manufacturing
Andy Walker
VP - R & D
Mark Frohlich
VP - Regulatory Affairs
Elizabeth Smith
Browse more venture capital transactions:
Prev: 4/24/2014: Aciex Therapeutics venture capital transaction
Next: 4/24/2014: Oris4 venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs